Abstract
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak
Highlights
While general hospitals across our region struggled to organize the response, which naturally focused on converting near-all activities to assist COVID-19 patients, our Institute’s mission to treat oncologic patients was preserved through measures implemented over a course of 2 weeks
A surveillance department within our center was created in order to screen oncologic patients with symptoms of infection and to contain already admitted
* Correspondence: Carlo.Resteghini@istitutotumori.mi.it 1Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milan, Italy Full list of author information is available at the end of the article subjects who developed the disease
Summary
While general hospitals across our region struggled to organize the response, which naturally focused on converting near-all activities to assist COVID-19 patients, our Institute’s mission to treat oncologic patients was preserved through measures implemented over a course of 2 weeks. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak Carlo Resteghini1*, Paola Maggioni1, Vito Di Martino1, Lisa Licitra1,2 on behalf of Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
